A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802.
Eur Urol
; 68(3): 365-71, 2015 Sep.
Article
in En
| MEDLINE
| ID: mdl-25533418
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Kallikreins
/
Prostate-Specific Antigen
/
Cancer Vaccines
/
Androgen Antagonists
Type of study:
Clinical_trials
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur Urol
Year:
2015
Document type:
Article
Country of publication: